CANCER GENETICS INC - COM (CGIX)

CUSIP: 13739U104

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / COM
Total 13F shares
2,119,453
Share change
-87,101
Total reported value
$23,951,250
Price per share
$11.30
Number of holders
34
Value change
-$3,215,586
Number of buys
20
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 13739U104?
CUSIP 13739U104 identifies CGIX - CANCER GENETICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CANCER GENETICS INC - COM (CGIX) as of Q2 2014

As of 30 Jun 2014, CANCER GENETICS INC - COM (CGIX) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,119,453 shares. The largest 10 holders included BANK OF MONTREAL /CAN/, NORTHPOINTE CAPITAL LLC, DEERFIELD MANAGEMENT CO, VANGUARD GROUP INC, COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS, GRUBER & MCBAINE CAPITAL MANAGEMENT LLC, Sterneck Capital Management, LLC, TFS CAPITAL LLC, GEODE CAPITAL MANAGEMENT, LLC, and DIKER MANAGEMENT LLC. This page lists 34 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.